AGL 40.00 No Change ▼ 0.00 (0%)
AIRLINK 131.00 Increased By ▲ 1.47 (1.13%)
BOP 6.95 Increased By ▲ 0.27 (4.04%)
CNERGY 4.63 No Change ▼ 0.00 (0%)
DCL 8.91 Decreased By ▼ -0.03 (-0.34%)
DFML 42.94 Increased By ▲ 1.25 (3%)
DGKC 84.25 Increased By ▲ 0.48 (0.57%)
FCCL 32.79 Increased By ▲ 0.02 (0.06%)
FFBL 78.24 Increased By ▲ 2.77 (3.67%)
FFL 12.16 Increased By ▲ 0.69 (6.02%)
HUBC 110.25 Decreased By ▼ -0.30 (-0.27%)
HUMNL 14.42 Decreased By ▼ -0.14 (-0.96%)
KEL 5.66 Increased By ▲ 0.27 (5.01%)
KOSM 8.37 Decreased By ▼ -0.03 (-0.36%)
MLCF 39.50 Decreased By ▼ -0.29 (-0.73%)
NBP 64.05 Increased By ▲ 3.76 (6.24%)
OGDC 201.70 Increased By ▲ 2.04 (1.02%)
PAEL 26.45 Decreased By ▼ -0.20 (-0.75%)
PIBTL 7.77 Increased By ▲ 0.11 (1.44%)
PPL 161.40 Increased By ▲ 3.48 (2.2%)
PRL 26.59 Decreased By ▼ -0.14 (-0.52%)
PTC 18.54 Increased By ▲ 0.08 (0.43%)
SEARL 83.00 Increased By ▲ 0.56 (0.68%)
TELE 8.20 Decreased By ▼ -0.11 (-1.32%)
TOMCL 34.37 Decreased By ▼ -0.14 (-0.41%)
TPLP 9.02 Decreased By ▼ -0.04 (-0.44%)
TREET 16.99 Decreased By ▼ -0.48 (-2.75%)
TRG 60.30 Decreased By ▼ -1.02 (-1.66%)
UNITY 27.70 Increased By ▲ 0.27 (0.98%)
WTL 1.41 Increased By ▲ 0.03 (2.17%)
BR100 10,722 Increased By 314.8 (3.03%)
BR30 32,041 Increased By 327.6 (1.03%)
KSE100 99,603 Increased By 2274.1 (2.34%)
KSE30 31,082 Increased By 889.9 (2.95%)
World

AstraZeneca says it will work with Dutch over vaccine queries

  • "Regulatory authorities in the UK, European Union, the World Health Organization have concluded that the benefits of using our vaccine to protect people from this deadly virus significantly outweigh the risks across all adult age groups," a spokesman for AstraZeneca said in a statement.
Published April 2, 2021

LONDON: AstraZeneca said on Friday it was working with Dutch authorities to address any questions they had after the Netherlands temporarily suspended use of its COVID-19 vaccine for people under 60 following the death of a woman who had received a shot.

"Regulatory authorities in the UK, European Union, the World Health Organization have concluded that the benefits of using our vaccine to protect people from this deadly virus significantly outweigh the risks across all adult age groups," a spokesman for AstraZeneca said in a statement.

"Tens of millions of people have now received our vaccine across the globe. The extensive body of data from two large clinical datasets and real-world evidence demonstrate its effectiveness, reaffirming the role the vaccine can play during this public health crisis."

Comments

Comments are closed.